Andrew Hirsch

Companies

• C4 Therapeutics (United States)Chief executive officer Feb 23, 2022 to now¹
• C4 Therapeutics (United States)President Feb 23, 2022 to now¹
• C4 Therapeutics (United States)Board member Oct 1, 2020 to now²
• Editas MedicineBoard member May 31, 2017 to now³
• C4 Therapeutics (United States)Officer Oct 1, 2020 to Oct 5, 2020²
• Agios PharmaceuticalsChief financial officer Sep 21, 2016 to Apr 24, 2020⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• C4 Therapeutics (United States) CCCC1,074,934 shares⁵$3.0M at $2.77Feb 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 15, 2026Shares withheld for tax 9,057 shares at $1.89 of C4 Therapeutics (United States)⁵
• Feb 15, 2026Exercised options 20,400 shares of C4 Therapeutics (United States)⁵
• Feb 14, 2026Shares withheld for tax 39,154 shares at $1.89 of C4 Therapeutics (United States)⁵
• Feb 14, 2026Exercised options 81,725 shares of C4 Therapeutics (United States)⁵
• Feb 13, 2026Granted 700,000 shares of C4 Therapeutics (United States)⁵
• Feb 15, 2025Shares withheld for tax 9,370 shares at $3.18 of C4 Therapeutics (United States)⁶
• Feb 14, 2025Shares withheld for tax 12,847 shares at $3.18 of C4 Therapeutics (United States)⁶
• Feb 14, 2025Granted 223,500 shares of C4 Therapeutics (United States)⁶
• Nov 7, 2024Shares withheld for tax 5,550 shares at $6.04 of C4 Therapeutics (United States)⁷
• Nov 7, 2024Exercised options 12,500 shares of C4 Therapeutics (United States)⁷
• Sep 16, 2024Shares withheld for tax 3,329 shares at $6.36 of C4 Therapeutics (United States)⁸
• Sep 16, 2024Exercised options 7,500 shares of C4 Therapeutics (United States)⁸
• Feb 15, 2024Shares withheld for tax 6,560 shares at $7.90 of C4 Therapeutics (United States)⁹
• Feb 14, 2024Granted 103,400 shares of C4 Therapeutics (United States)¹⁰
• Aug 30, 2023Shares withheld for tax 2,205 shares at $2.93 of C4 Therapeutics (United States)¹¹
• Aug 30, 2023Exercised options 7,500 shares of C4 Therapeutics (United States)¹¹
• Feb 15, 2023Granted 81,600 shares of C4 Therapeutics (United States)¹²
• Jan 30, 2023Shares withheld for tax 4,319 shares at $7.78 of C4 Therapeutics (United States)¹³
• Jan 30, 2023Exercised options 12,500 shares of C4 Therapeutics (United States)¹³
• May 26, 2022Shares withheld for tax 3,675 shares at $7.01 of C4 Therapeutics (United States)¹⁴
• May 25, 2022Exercised options 12,500 shares of C4 Therapeutics (United States)¹⁵
• Apr 12, 2022Bought 10,000 shares at $8.40 of C4 Therapeutics (United States)¹⁶